DRUG

danuglipron

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for danuglipron

Pancreatic cancer 1

Mediator Outcome Score Tier Lit. status Trial
GLP-1R pancreatic ductal adenocarcinoma 0.208 Mid novel signal none

Clinical trials

20 registered trials for danuglipron

Source: ClinicalTrials.gov

← All drugs